Skip to main content
. 2017 Apr 17;17:272. doi: 10.1186/s12885-017-3258-9

Fig. 4.

Fig. 4

Mean value contributions* of each quantitative criterion and overall MCDA value estimates† for lenvatinib for RR-DTC from the French (a), Italian (b), and Spanish (c) panels versus watchful waiting (1) and sorafenib (2). * Value contribution = Normalized weight ×standardized score; †Overall Value Estimate = ∑ Value contribution of all 12 criteria. Error bars show standard deviations across 8 panelists in each country-specific panel